Helius Medical Technologies is trading 5.01% lower at $2.23; broader market weakness is a plausible backdrop, not a confirmed cause. - No clear company-specific announcement explaining the decline on October 14, 2026, surfaced in search results. - U.S. stocks weakened after September CPI rose 3.7% year over year, above the 3.6% forecast. - Markets raised expectations for a possible Fed rate hike, but this macro pressure does not establish a direct cause for the stock’s decline.